Mercom Capital Group October 14, 2021
Staff

Deerfield Management Company led the Series A funding round

DeepSight Technology, a diagnostic medical imaging platform, announced a $25 million Series A led by Deerfield Management Company, a healthcare investment firm, with additional funding from Wing, Alter Venture Partners, and Time BioVentures.

“DeepSight Technology provides a potential platform opportunity to enhance non-invasive and invasive medical imaging for multiple diagnostic procedures, and in turn, improve the patient care process with more efficacious testing that costs less,” said Steven Hochberg, Partner at Deerfield.

Steven Hochberg added: “We are pleased to be leading this Series A financing in a novel medical device technology which has the potential to help advance a range of imaging procedures.”

DeepSight is augmenting diagnostic medical imaging by introducing...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Investments, Medical Devices, Provider, Trends
Exo adds FDA-cleared AI tools to handheld ultrasound system
FDA spends $1.2M on VR-enabled hub to spur development of at-home care devices
FDA launches initiative to advance home healthcare models, devices
Is Telepathy Possible? Perhaps, Due To New Technology
FDA Proposes Updated Guidance Concerning Cybersecurity of Medical Devices

Share This Article